company background image
CSPC.Y logo

CSPC Pharmaceutical Group OTCPK:CSPC.Y Stock Report

Last Price

US$3.24

Market Cap

US$9.7b

7D

-0.6%

1Y

-15.6%

Updated

25 Mar, 2024

Data

Company Financials +

CSPC Pharmaceutical Group Limited

OTCPK:CSPC.Y Stock Report

Market Cap: US$9.7b

CSPC.Y Stock Overview

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally.

CSPC.Y fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends3/6

CSPC Pharmaceutical Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CSPC Pharmaceutical Group
Historical stock prices
Current Share PriceHK$3.24
52 Week HighHK$4.11
52 Week LowHK$2.63
Beta0.72
1 Month Change2.53%
3 Month Change-7.69%
1 Year Change-15.63%
3 Year Change-31.79%
5 Year Changen/a
Change since IPO8.76%

Recent News & Updates

Recent updates

Shareholder Returns

CSPC.YUS PharmaceuticalsUS Market
7D-0.6%-0.06%2.1%
1Y-15.6%23.6%30.4%

Return vs Industry: CSPC.Y underperformed the US Pharmaceuticals industry which returned 23.6% over the past year.

Return vs Market: CSPC.Y underperformed the US Market which returned 30.4% over the past year.

Price Volatility

Is CSPC.Y's price volatile compared to industry and market?
CSPC.Y volatility
CSPC.Y Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.0%

Stable Share Price: CSPC.Y has not had significant price volatility in the past 3 months.

Volatility Over Time: CSPC.Y's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199223,500Cuilong Zhanghttps://www.cspc.com.hk

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer.

CSPC Pharmaceutical Group Limited Fundamentals Summary

How do CSPC Pharmaceutical Group's earnings and revenue compare to its market cap?
CSPC.Y fundamental statistics
Market capUS$9.74b
Earnings (TTM)US$812.46m
Revenue (TTM)US$4.35b

12.0x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CSPC.Y income statement (TTM)
RevenueCN¥31.45b
Cost of RevenueCN¥9.27b
Gross ProfitCN¥22.18b
Other ExpensesCN¥16.30b
EarningsCN¥5.87b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.50
Gross Margin70.51%
Net Profit Margin18.68%
Debt/Equity Ratio1.3%

How did CSPC.Y perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

51%

Payout Ratio

Does CSPC.Y pay a reliable dividends?

See CSPC.Y dividend history and benchmarks
When do you need to buy CSPC.Y by to receive an upcoming dividend?
CSPC Pharmaceutical Group dividend dates
Ex Dividend DateJun 03 2024
Dividend Pay DateJul 11 2024
Days until Ex dividend69 days
Days until Dividend pay date107 days

Does CSPC.Y pay a reliable dividends?

See CSPC.Y dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.